Phathom Pharmaceuticals Inc (PHAT)
7.50
-0.11
(-1.45%)
USD |
NASDAQ |
Dec 24, 16:00
Phathom Pharmaceuticals Profit Margin (Quarterly): -523.3% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 18.95% |
| Galectin Therapeutics Inc | -- |
| AbbVie Inc | 10.80% |
| Poseida Therapeutics Inc | 28.20% |
| Janux Therapeutics Inc | -6.39K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -91.94% |
| Gross Profit Margin (Quarterly) | 85.59% |
| Operating Margin (Quarterly) | -433.0% |
| Return on Net Operating Assets | -2.36K% |